Loading clinical trials...
Loading clinical trials...
The goal of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of a digital intervention called LDART in adults with stimulant use disorder.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Yale University
Collaborators
NCT07227948 · Cocaine Use Disorder
NCT07071779 · Alcohol Use Disorder (AUD), Cocaine Use Disorder (CUD), and more
NCT04927143 · Opioid-use Disorder, Cocaine Use Disorder, and more
NCT06790576 · Stimulant Use Disorder
NCT07033416 · Training for Cocaine Use Disorder
Yale University
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions